HIV PrEP also prevents hepatitis B – and works better than the hepatitis B vaccine
HIV-positive people with fatty liver disease are at high risk for fibrosis
Hepatitis B treatment suboptimal in people with HIV in Africa
Hepatitis C screening among PrEP users could eliminate hepatitis C infections in gay men in the UK
Tesamorelin reduces liver fat and fibrosis progression in people with HIV and non-alcoholic fatty liver disease
Hepatitis C incidence is low among Canadian men on PrEP
Coalition of liver associations call for simplifying hepatitis C care
Hepatitis C vaccine fails to prevent chronic infection
Fatty liver raises the risk of death in people with HIV and hepatitis C